Synthesis and HDAC inhibitory activity of pyrimidine-based hydroxamic acids

Scholarly Works

• Bertašiūtė, M.; Šiugždaitė, J.; Grybaitė, B.; Sapijanskaitė-Banevič, B.; Tubytė, L.; Lelešius, R.; Belyakov, S.; Marksa, M.; Ževžikovas, A.; Mickevičius, V. New 3-(6-Bromo-2-oxo-1,3-benzoxazol-3(2H)-yl)propanoic Acid Derivatives: Synthesis and Biological Activity Against Bacterial Pathogens. Applied Sciences 2026, 16, 2096. doi:10.3390/app16042096
• Cervantes, Z.; Bradford, L.; Antonini Bertolazzo, A.; Mahendran, A.; Stieber, S. C. E. Synthesis and crystal structure of HDAC6 selective inhibitor of N-hy-droxy-4-{2-[(2-hy-droxy-eth-yl)(phen-yl)amino]-2-oxoeth-yl}benzamide monohydrate (HPOB·H2O). Acta crystallographica. Section E, Crystallographic communications 2026, 82, 132–137. doi:10.1107/s2056989025010989
• Gagare, S. S.; Choudhari, V. P.; Jain, A. S.; Mali, S. N.; Gurav, S. S. Synthesis, Antiproliferative Activity Evaluation, and Molecular Docking Analysis of N-Hydroxy-2-[4-(2-R1,3-R2,6-R3-quinolin-4-yl)phenyl]acetamides as Promising HDAC8 Inhibitors. Russian Journal of Organic Chemistry 2025, 61, 2152–2163. doi:10.1134/s1070428025601347
• Jakubkiene, V.; Kopranovic, A.; Meyer-Almes, F.-J.; Tumkevicius, S. Synthesis and HDAC inhibitory activity of pyrimidine-based amidoximes, 1,2,4-oxadiazoles, and 1,2,3,5-oxathiadiazoles. Chemistry of Heterocyclic Compounds 2025, 61, 262–267. doi:10.1007/s10593-025-03412-9
• Gagare, S. S.; Choudhari, V. P.; Jain, A. S.; Mali, S. N. Biological Evaluation and Molecular Docking Study of (E)-N-(2-Aminophenyl)-3-(quinolin-4-yl)acrylamides as Potential Anticolon Cancer Agents. Russian Journal of Organic Chemistry 2025, 61, 902–910. doi:10.1134/s1234567824603966
• Yan, S.; Kowah, J. A. H.; Long, Q.; Liu, Q.; Zhang, H.; Lu, S.; Wang, L.; Yu, H. Design, synthesis and antifungal activity of novel matrine-hydroxamic acid derivatives containing benzene sulfonamide. RSC advances 2025, 15, 16510–16524. doi:10.1039/d5ra01689d
• Cacabelos, R.; Naidoo, V.; Tellado, I.; Corzo, L.; Cacabelos, N.; Cacabelos, P.; Martínez-Iglesias, O.; Segre, R. Epigenetic drugs. Pharmacoepigenetics; Elsevier, 2025; pp 214–624. doi:10.1016/b978-0-443-18722-3.00029-3
• Jakubkiene, V.; Labalaukyte, I.; Schweipert, M.; Zubriene, A.; Meyer‐Almes, F.; Matulis, D.; Tumkevicius, S. Synthesis and histone deacetylases inhibitory activity of pyrimidine‐based 1,3,4‐oxadiazoles. Journal of Heterocyclic Chemistry 2024, 61, 1426–1438. doi:10.1002/jhet.4867
• Aslanoglu, F.; Yazıcı, A. 6-methylthiouracil and 6-methyluracil derivatives synthesized by reaction of acetylketene with thiourea and urea compounds in presence of Yb(TFA) 3. Synthetic Communications 2023, 53, 1713–1721. doi:10.1080/00397911.2023.2245506
• Badran, M. M.; Abbas, S. H.; Fujita, M.; Abdel-Aziz, M. Harnessing pyrimidine as a building block for histone deacetylase inhibitors. Archiv der Pharmazie 2023, 356, e2300208. doi:10.1002/ardp.202300208

Explore citations to this article at